Back to Newsroom
NRHS Receives funding from Susan G. Komen for the Cure
Norman – For the second year in a row, the Mammogram Initiative at Norman Regional Health System (NRHS) has received a generous grant from the Central Oklahoma Affiliate of Susan G. Komen for the Cure®. The Mammogram Initiative is dedicated to improving breast health in south-central Oklahoma.
This program teaches all women about breast cancer risks and preventative measures; targeting women over the age of 40 who have not had a mammogram in the past year. The Mammogram Initiative has been in place for the past year and already several women that scheduled mammograms through the program have had atypical results and are waiting on further tests. One woman has officially been diagnosed with breast cancer and without the Mammogram Initiative, her cancer may not have been found as early.
“I cannot stress enough the importance of routine mammography on an annual basis. A woman’s chances of surviving breast cancer are the highest if it is detected early. In most cases, mammography can detect cancer before it can be felt, that is the time to treat it and beat it,” stated Cindy Barghols, NRHS Supervisor of Mammography.
Mammography is the tool of choice for detecting breast cancer at the earliest possible stage by watching for the changes that occur in the breast tissue. Women over the age of 40 are encouraged to do a routine mammogram on an annual basis. An annual mammogram allows the interpreting radiologist the opportunity to compare the images from year to year in order to watch for these breast tissue changes. In addition to digital and film mammography, NRHS now offers breast magnetic resonance imaging (MRI).
Breast cancer is the most common cancer diagnosed at NRHS. When identified early, breast cancer is most treatable, and the related instances of prolonged illness and death are greatly reduced. From 2000-2006, Norman Regional reported 922 cases of breast cancer, and over 381, or 41%, of those cases were diagnosed at Stage II or later. NRHS wants to identify breast cancer early, when it is most treatable.
Back to Newsroom